• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受韩医学治疗的转移性结直肠癌患者健康相关生活质量与生存之间的关系

The Relationship Between Health-Related Quality of Life and Survival in Metastatic Colorectal Cancer Patients Treated With Korean Medicine.

作者信息

Park Sora, Eo Wankyu, Lee Sookyung

机构信息

1 Kyung Hee University, Seoul, Republic of Korea.

出版信息

Integr Cancer Ther. 2018 Mar;17(1):65-72. doi: 10.1177/1534735416684015. Epub 2016 Dec 26.

DOI:10.1177/1534735416684015
PMID:28024424
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5950943/
Abstract

OBJECTIVES

This study aimed to identify the relationship between health-related quality of life (HRQoL) measured by the Functional Assessment Cancer Therapy-General (FACT-G) and survival in metastatic colorectal cancer (mCRC) patients.

METHODS

The clinical characteristics and FACT-G scores were retrospectively reviewed in mCRC patients who visited the Cancer Center of Korean Medicine. The overall survival (OS) was calculated and compared using the Kaplan-Meier method and log-rank test. Univariate and multivariate Cox regression analyses were performed based on clinical characteristics and FACT-G scores. To identify significant differences in answer frequency, χ tests and Fisher's exact tests were used.

RESULTS

A total of 58 patients were reviewed. The proportion of patients who had an Eastern Cooperative Oncology Group-Performance Status ≥ 2 was 43.1%, multiple distant metastatic sites was 77.6%, liver metastases was 43.1%, been previously treated was 89.7%, and received more than the second-line chemotherapy was 75.5%. The mean total FACT-G score was 65.3 (median 65.6). The median OS was 7 months. There was no significant difference in OS between the 2 groups divided by the median values of FACT-G total and subscores. In univariate analyses, functional well-being (FWB) score had a significant impact on survival. In multivariate analyses, presence of liver metastasis, FACT-G total score, and FWB score were significant prognostic predictors of survival. No statistically different answer frequency was observed for any question regarding FWB.

CONCLUSIONS

This study found that FACT-G total and FWB scores were potential prognostic factors for predicting OS in relapsed or refractory mCRC patients treated with Korean Medicine.

摘要

目的

本研究旨在确定通过癌症治疗功能评估通用量表(FACT-G)测量的健康相关生活质量(HRQoL)与转移性结直肠癌(mCRC)患者生存率之间的关系。

方法

对就诊于韩国医学癌症中心的mCRC患者的临床特征和FACT-G评分进行回顾性分析。采用Kaplan-Meier法和对数秩检验计算并比较总生存期(OS)。基于临床特征和FACT-G评分进行单因素和多因素Cox回归分析。为确定回答频率的显著差异,使用χ检验和Fisher精确检验。

结果

共纳入58例患者进行分析。东部肿瘤协作组体能状态≥2的患者比例为43.1%,有多个远处转移部位的患者比例为77.6%,有肝转移的患者比例为43.1%,既往接受过治疗的患者比例为89.7%,接受过二线以上化疗的患者比例为75.5%。FACT-G总评分的平均值为65.3(中位数为65.6)。中位总生存期为7个月。根据FACT-G总分及各子评分的中位数将患者分为两组,两组的总生存期无显著差异。单因素分析中,功能幸福感(FWB)评分对生存有显著影响。多因素分析中,肝转移的存在、FACT-G总分及FWB评分是生存的显著预后预测因素。关于FWB的任何问题,均未观察到有统计学差异的回答频率。

结论

本研究发现,FACT-G总分及FWB评分是预测接受韩医治疗的复发或难治性mCRC患者总生存期的潜在预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97b/5950943/615c81595410/10.1177_1534735416684015-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97b/5950943/1b3b12895085/10.1177_1534735416684015-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97b/5950943/615c81595410/10.1177_1534735416684015-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97b/5950943/1b3b12895085/10.1177_1534735416684015-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97b/5950943/615c81595410/10.1177_1534735416684015-fig2.jpg

相似文献

1
The Relationship Between Health-Related Quality of Life and Survival in Metastatic Colorectal Cancer Patients Treated With Korean Medicine.接受韩医学治疗的转移性结直肠癌患者健康相关生活质量与生存之间的关系
Integr Cancer Ther. 2018 Mar;17(1):65-72. doi: 10.1177/1534735416684015. Epub 2016 Dec 26.
2
Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.复发或难治性转移性结直肠癌患者中基于炎症的选定预后标志物的比较。
World J Gastroenterol. 2015 Nov 21;21(43):12410-20. doi: 10.3748/wjg.v21.i43.12410.
3
Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.广泛期小细胞肺癌患者接受培美曲塞加卡铂与依托泊苷加卡铂治疗的预后因素:基线生活质量和体能状态。
Lung Cancer. 2012 Dec;78(3):276-81. doi: 10.1016/j.lungcan.2012.09.002. Epub 2012 Oct 6.
4
Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study.化疗诱导的1个月时中性粒细胞减少是接受TAS-102治疗难治性转移性结直肠癌患者总生存期的预测指标:一项队列研究。
BMC Cancer. 2016 Jul 13;16:467. doi: 10.1186/s12885-016-2491-y.
5
Serum Ferritin as a Prognostic Biomarker for Survival in Relapsed or Refractory Metastatic Colorectal Cancer.血清铁蛋白作为复发或难治性转移性结直肠癌生存的预后生物标志物
J Cancer. 2016 May 12;7(8):957-64. doi: 10.7150/jca.14797. eCollection 2016.
6
Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.淋巴细胞与单核细胞比值可预测结直肠癌肝转移射频消融术后的生存率。
World J Gastroenterol. 2016 Apr 28;22(16):4211-8. doi: 10.3748/wjg.v22.i16.4211.
7
Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis.临床实践中≥75岁转移性结直肠癌患者的治疗:一项多中心分析
PLoS One. 2016 Jul 21;11(7):e0157751. doi: 10.1371/journal.pone.0157751. eCollection 2016.
8
Longterm effects of palliative local treatment of incurable metastatic lesions in colorectal cancer patients.姑息性局部治疗对结直肠癌不可治愈性转移病灶患者的长期影响。
Oncotarget. 2016 Apr 12;7(15):21034-45. doi: 10.18632/oncotarget.8090.
9
High- versus low-dose leucovorin in the modified FOLFOX6 regimen for first-line treatment of metastatic colorectal cancer.用于转移性结直肠癌一线治疗的改良FOLFOX6方案中高剂量与低剂量亚叶酸钙的比较
J Oncol Pharm Pract. 2017 Apr;23(3):173-178. doi: 10.1177/1078155215623085. Epub 2016 Jun 22.
10
Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program.瑞戈非尼用于标准治疗难治性转移性结直肠癌患者的生存、安全性及预后因素:一项嵌套于同情用药项目中的多中心研究(REBECCA)结果
BMC Cancer. 2016 Jul 7;16:412. doi: 10.1186/s12885-016-2440-9.

引用本文的文献

1
Reverse Time-to-Death as Time-Scale in Time-to-Event Analysis for Studies of Advanced Illness and Palliative Care.在晚期疾病和姑息治疗研究的事件发生时间分析中,将反向死亡时间用作时间尺度。
Stat Med. 2025 Feb 10;44(3-4):e10338. doi: 10.1002/sim.10338.
2
Global quality of life and mortality risk in patients with cancer: a systematic review and meta-analysis.癌症患者的全球生活质量和死亡风险:系统评价和荟萃分析。
Qual Life Res. 2024 Oct;33(10):2631-2643. doi: 10.1007/s11136-024-03691-3. Epub 2024 May 29.
3
Baseline functioning scales of EORTC QLQ-C30 predict overall survival in patients with gastrointestinal cancer: a meta-analysis.

本文引用的文献

1
Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer?健康相关生活质量评分的变化能否预测 III 期和 IV 期结直肠癌的生存情况?
Health Qual Life Outcomes. 2011 Aug 3;9:62. doi: 10.1186/1477-7525-9-62.
2
Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations.在癌症临床研究中选择 EORTC QLQ-C30 和 FACT-G 来测量健康相关的生活质量:问题、证据和建议。
Ann Oncol. 2011 Oct;22(10):2179-90. doi: 10.1093/annonc/mdq721. Epub 2011 Feb 21.
3
Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008.
EORTC QLQ-C30 基线功能量表预测胃肠道癌症患者的总生存:一项荟萃分析。
Qual Life Res. 2024 Jun;33(6):1455-1468. doi: 10.1007/s11136-023-03591-y. Epub 2024 Jan 16.
4
The effectiveness of community dance in people with cancer: a mixed-methods systematic review and meta-analysis.社区舞蹈对癌症患者的有效性:一项混合方法系统评价和荟萃分析。
Health Promot Int. 2023 Aug 1;38(4). doi: 10.1093/heapro/daad077.
5
The Quality of Life of Patients with Surgically Treated Colorectal Cancer: A Narrative Review.手术治疗的结直肠癌患者的生活质量:一项叙述性综述。
J Clin Med. 2022 Oct 21;11(20):6211. doi: 10.3390/jcm11206211.
6
Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study.在芬兰RAXO研究中,接受根治性切除和/或局部消融治疗或全身治疗的转移性结直肠癌患者的健康相关生活质量
Cancers (Basel). 2022 Mar 28;14(7):1713. doi: 10.3390/cancers14071713.
7
Quality of life for older patients with cancer: a review of the evidence supporting melatonin use.癌症老年患者的生活质量:支持使用褪黑素的证据综述。
Aging Clin Exp Res. 2020 Dec;32(12):2459-2468. doi: 10.1007/s40520-020-01532-0. Epub 2020 Mar 31.
8
Role of clinical oncology pharmacist in determination of pharmaceutical care needs in patients with colorectal cancer.临床肿瘤药师在确定结直肠癌患者药学服务需求中的作用。
Eur J Hosp Pharm. 2018 Mar;25(e1):e17-e20. doi: 10.1136/ejhpharm-2016-001188. Epub 2017 Mar 10.
生活质量数据作为癌症患者生存预后指标的研究:1982 年至 2008 年文献综述。
Health Qual Life Outcomes. 2009 Dec 23;7:102. doi: 10.1186/1477-7525-7-102.
4
Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE).贝伐珠单抗用于一线治疗进展后的转移性结直肠癌可延长总生存期:一项大型观察性队列研究(BRiTE)的结果
J Clin Oncol. 2008 Nov 20;26(33):5326-34. doi: 10.1200/JCO.2008.16.3212. Epub 2008 Oct 14.
5
Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer.验证患者自我报告的社会功能作为转移性结直肠癌患者生存的独立预后因素:欧洲癌症研究与治疗组织时辰治疗小组的一项国际研究结果
J Clin Oncol. 2008 Apr 20;26(12):2020-6. doi: 10.1200/JCO.2007.12.3117.
6
Identifying prognostic factors for survival in advanced cancer patients: a prospective study.确定晚期癌症患者生存的预后因素:一项前瞻性研究。
Hong Kong Med J. 2007 Dec;13(6):453-9.
7
Quality of life as a predictor of cancer survival among Chinese liver and lung cancer patients.中国肝癌和肺癌患者的生活质量作为癌症生存的预测指标
Eur J Cancer. 2007 Jul;43(11):1723-30. doi: 10.1016/j.ejca.2007.05.002. Epub 2007 Jun 27.
8
Equating EORTC QLQ-C30 and FACT-G scores and its use in oncological research.欧洲癌症研究与治疗组织核心生活质量问卷C30(EORTC QLQ-C30)与癌症治疗功能评价系统通用量表(FACT-G)评分的等效性及其在肿瘤学研究中的应用。
Eur J Cancer. 2006 Dec;42(18):3169-77. doi: 10.1016/j.ejca.2006.08.016. Epub 2006 Oct 11.
9
Inhibition of cell cycle progression via p27Kip1 upregulation and apoptosis induction by an ethanol extract of Rhus verniciflua Stokes in AGS gastric cancer cells.漆树乙醇提取物通过上调p27Kip1抑制AGS胃癌细胞的细胞周期进程并诱导凋亡。
Int J Mol Med. 2006 Jul;18(1):201-8.
10
Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?在晚期结直肠癌患者中,患者自我报告的健康相关生活质量能否在关键生物医学数据之外预测生存情况?
Eur J Cancer. 2006 Jan;42(1):42-9. doi: 10.1016/j.ejca.2005.07.025. Epub 2005 Nov 18.